Cytokinetics Inc (CYTK)

Jul 30, 2025

Levi & Korsinsky Announces an Investigation on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire

Jul 30, 2025

Jul 30, 2025

Institutional Tools Highlight Unusual Flow in Cytokinetics IncorporatedWeekly Chart Analysis With Entry Advice Provided - metal.it

Jul 30, 2025

Jul 29, 2025

Raymond James downgrades Cytokinetics stock rating to Market Perform By Investing.com - Investing.com Canada

Jul 29, 2025

Jul 29, 2025

Cytokinetics, Incorporated Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsCYTK - ACCESS Newswire

Jul 29, 2025

Jul 29, 2025

Cytokinetics Incorporated Stock Support and Resistance Levels You Should KnowRisk Controlled Picks With Real Returns Outlined - metal.it

Jul 29, 2025

Jul 28, 2025

Why Cytokinetics Incorporated stock attracts strong analyst attentionEarnings Play Trade Plan With Alerts Shared - metal.it

Jul 28, 2025

Jul 28, 2025

Cytokinetics Incorporated Earnings Report Breakdown: What Investors Should KnowInvestment Playbook for Growing Markets Shared - metal.it

Jul 28, 2025

Jul 28, 2025

Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT - MSN

Jul 28, 2025

Jul 28, 2025

Cytokinetics, Incorporated (CYTK) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire

Jul 28, 2025

Jul 28, 2025

What makes Cytokinetics Incorporated stock price move sharplyBuild wealth faster with consistent investment plans - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

How strong is Cytokinetics Incorporated company’s balance sheetUnlock exclusive stock market forecasts - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What are analysts’ price targets for Cytokinetics Incorporated in the next 12 monthsDiscover undervalued opportunities early - jammulinksnews.com

Jul 27, 2025

Jul 26, 2025

Cytokinetics (CYTK): Is the FDA Delay a Buying Opportunity for Aficamten's Long-Term Payoff? - AInvest

Jul 26, 2025

Jul 25, 2025

Levi & Korsinsky Reminds Cytokinetics, Incorporated Investors of the Ongoing Investigation into Potential Violations of Securities LawsCYTK - ACCESS Newswire

Jul 25, 2025

Jul 25, 2025

Cytokinetics Incorporated Stock Analysis and ForecastSpectacular growth rates - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Cytokinetics Sets Key Q2 Earnings Date: What Investors Should Watch on August 7 - Stock Titan

Jul 24, 2025

Jul 24, 2025

What risks could impact Cytokinetics Incorporated stock performanceExceptional trading performance - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Cytokinetics, Incorporated (CYTK) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Jul 24, 2025

Jul 23, 2025

Top Executive Sells Cytokinetics Stock in a Major Move - TipRanks

Jul 23, 2025

Jul 23, 2025

What drives Cytokinetics Incorporated stock priceRapid portfolio appreciation - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What analysts say about Cytokinetics Incorporated stockFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Cytokinetics Incorporated a good long term investmentOutstanding trading profits - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Shareholders that lost money on Cytokinetics, Incorporated (CYTK) should contact Levi & Korsinsky about Securities Fraud InvestigationCYTK - ACCESS Newswire

Jul 22, 2025

Jul 21, 2025

Cytokinetics, Incorporated INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cytokinetics, Incorporated (CYTK) - ACCESS Newswire

Jul 21, 2025

Jul 21, 2025

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Jul 21, 2025

Jul 18, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Jul 18, 2025

Jul 18, 2025

Cytokinetics Awards 220,000 Shares in Employee Stock Grants at $38.68 Strike Price - Stock Titan

Jul 18, 2025

Jul 18, 2025

Cytokinetics’ Aficamten Study: A New Hope for Pediatric Heart Patients - TipRanks

Jul 18, 2025

Jul 15, 2025

Cytokinetics CEO Makes a Significant Stock Move! - TipRanks

Jul 15, 2025

Jul 15, 2025

Cytokinetics (CYTK) CEO Blum sells $190k in stock By Investing.com - Investing.com Nigeria

Jul 15, 2025

Jul 15, 2025

Cytokinetics (CYTK) CEO Blum sells $190k in stock - Investing.com

Jul 15, 2025

Jul 11, 2025

CYTK ALERTLevi & Korsinsky Has Commenced an Investigation on Behalf of Cytokinetics, Incorporated Shareholders Who Lost Money - ACCESS Newswire

Jul 11, 2025

Jul 10, 2025

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 - The Manila Times

Jul 10, 2025

Jul 10, 2025

Cytokinetics to Showcase Positive Aficamten Results for Obstructive Hypertrophic Cardiomyopathy at European Society of Cardiology Congress 2025 - Nasdaq

Jul 10, 2025

Jul 10, 2025

Major Clinical Trial Results: Cytokinetics Reveals New Aficamten Data vs Metoprolol in HCM Treatment - Stock Titan

Jul 10, 2025

Jul 09, 2025

Cytokinetics(CYTK) Soars 6.93% on Analyst Optimism - AInvest

Jul 09, 2025

Jul 09, 2025

Cytokinetics, Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsCYTK - ACCESS Newswire

Jul 09, 2025